Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (151-160 of 415) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2023
A Case of Mpox ReinfectionStefano Musumeci, Iris Najjar, Emmanuelle Boffi El Amari, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2021
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort studyBernadette Jakeman, Alexandra Scherrer, Manuel Battegay, et al.
AIDS Research and Therapy|June 23, 2015
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disordersCharlotte M Verolet, Cécile Delhumeau-Cartier, Marlène Sartori, et al.
Atherosclerosis|March 5, 2019
Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohortBaris Gencer, Sabrina Pagano, Nicolas Vuilleumier, et al.
HIV Clinical Trials|June 21, 2014
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneQing Wang, Jim Young, Enos Bernasconi, et al.
AIDS (London, England)|December 4, 2004
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudineMilos Opravil, Doris Baumann, Jean-Philippe Chave, et al.
The American Journal of Cardiology|January 2, 2013
Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infectionMihir Gupta, Christopher J Miller, Jason V Baker, et al.
AIDS (London, England)|November 30, 2020
Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trialJanine M Trevillyan, Anthony Dart, Eldho Paul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2012
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemicGilles Wandeler, Thomas Gsponer, Andrea Bregenzer, et al.
The New England Journal of Medicine|July 25, 2019
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1, Charles Kouanfack, Mireille Mpoudi-Etame, et al.
Pageof 42

Showing results (151-160 of 415) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2023
A Case of Mpox ReinfectionStefano Musumeci, Iris Najjar, Emmanuelle Boffi El Amari, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2021
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort studyBernadette Jakeman, Alexandra Scherrer, Manuel Battegay, et al.
AIDS Research and Therapy|June 23, 2015
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disordersCharlotte M Verolet, Cécile Delhumeau-Cartier, Marlène Sartori, et al.
Atherosclerosis|March 5, 2019
Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohortBaris Gencer, Sabrina Pagano, Nicolas Vuilleumier, et al.
HIV Clinical Trials|June 21, 2014
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneQing Wang, Jim Young, Enos Bernasconi, et al.
AIDS (London, England)|December 4, 2004
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudineMilos Opravil, Doris Baumann, Jean-Philippe Chave, et al.
The American Journal of Cardiology|January 2, 2013
Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infectionMihir Gupta, Christopher J Miller, Jason V Baker, et al.
AIDS (London, England)|November 30, 2020
Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trialJanine M Trevillyan, Anthony Dart, Eldho Paul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2012
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemicGilles Wandeler, Thomas Gsponer, Andrea Bregenzer, et al.
The New England Journal of Medicine|July 25, 2019
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1, Charles Kouanfack, Mireille Mpoudi-Etame, et al.
Pageof 42